Aaron Thomas Anderson

Dr. Aaron Thomas Anderson

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 July 2016 in Human Brain Mapping
Verified
Journal Article
Open access
PDF file
CJCurtis L Johnson
Curtis L Johnson
HSHillary Schwarb
Hillary Schwarb
MMMatthew D.J. McGarry
Matthew D.J. McGarry
AAAaron Thomas Anderson
Aaron Thomas Anderson
GHGraham R. Huesmann
Graham R. Huesmann
NCNeal J. Cohen
Neal J. Cohen
Viscoelastic mechanical properties of the brain assessed with magnetic resonance elastography (MRE) are sensitive measures of microstructural tissue health in neurodegenerative conditions. Recent efforts have targeted measurements localized to specific neuroanatomical regions differentially affected in disease. In this work, we present a method for measuring the viscoelasticity in subcortical gray matter (SGM) structures, including the amygdala, hippocampus, caudate, putamen, pallidum, and thalamus. The method is based on incorporating high spatial resolution MRE imaging (1.6 mm isotropic voxels) with a mechanical inversion scheme designed to improve local measures in pre‐defined regions (soft prior regularization [SPR]). We find that in 21 healthy, young volunteers SGM structures differ from each other in viscoelasticity, quantified as the shear stiffness and damping ratio, but also differ from the global viscoelasticity of the cerebrum. Through repeated examinations on a single volunteer, we estimate the uncertainty to be between 3 and 7% for each SGM measure. Furthermore, we demonstrate that the use of specific methodological considerations—higher spatial resolution and SPR—both decrease uncertainty and increase sensitivity of the SGM measures. The proposed method allows for reliable MRE measures of SGM viscoelasticity for future studies of neurodegenerative conditions. Hum Brain Mapp 37:4221–4233, 2016. © 2016 Wiley Periodicals, Inc.

1 June 2016 in Journal of the Mechanical Behavior of Biomedical Materials
Verified
Journal Article
Closed access
AAAaron Thomas Anderson
Aaron Thomas Anderson
EHElijah E.W. Van Houten
Elijah E.W. Van Houten
MMMatthew D.J. McGarry
Matthew D.J. McGarry
KPKeith D. Paulsen
Keith D. Paulsen
JHJoseph L. Holtrop
Joseph L. Holtrop
CJCurtis L Johnson
Curtis L Johnson

4 June 2012
Verified
Conference Paper
Closed access
AAAaron Thomas Anderson
Aaron Thomas Anderson
JFJonathan Freund
Jonathan Freund

3 January 2024 in IEEE Transactions on Biomedical Engineering
Verified
Journal Article
Open access
ZWZepeng Wang
Zepeng Wang
YLYahang Li
Yahang Li
CCChang Cao
Chang Cao
AAAaron Thomas Anderson
Aaron Thomas Anderson
GHGraham Huesmann
Graham Huesmann
FLFan Lam
Fan Lam
Objective: To develop a novel multi-TE MR spectroscopic imaging (MRSI) approach to enable label-free, simultaneous, high-resolution mapping of several molecules and their biophysical parameters in the brain. Methods: The proposed method uniquely integrated an augmented molecular-component-specific subspace model for multi-TE $^{1}$H-MRSI signals, an estimation-theoretic experiment optimization (nonuniform TE selection) for molecule separation and parameter estimation, a physics-driven subspace learning strategy for spatiospectral reconstruction and molecular quantification, and a new accelerated multi-TE MRSI acquisition for generating high-resolution data in clinically relevant times. Numerical studies, phantom and in vivo experiments were conducted to validate the optimized experiment design and demonstrate the imaging capability offered by the proposed method. Results: The proposed TE optimization improved estimation of metabolites, neurotransmitters and their $T_{2}$’s over conventional TE choices, e.g., reducing variances of neurotransmitter concentration by $\sim\! 40\%$ and metabolite $T_{2}$ by $\sim\! 60\%$. Simultaneous metabolite and neurotransmitter mapping of the brain can be achieved at a nominal resolution of 3.4 × 3.4 × 6.4 mm$^{3}$. High-resolution, 3D metabolite $T_{2}$ mapping was made possible for the first time. The translational potential of the proposed method was demonstrated by mapping biochemical abnormality in a post-traumatic epilepsy (PTE) patient. Conclusion: The feasibility for high-resolution mapping of metabolites/neurotransmitters and metabolite $T_{2}$’s within clinically relevant time was demonstrated. We expect our method to offer richer information for revealing and understanding metabolic alterations in neurological diseases. Significance: A novel multi-TE MRSI approach was presented that enhanced the technological capability of multi-parametric molecular imaging of the brain. The proposed method presents new technology development and application opportunities for providing richer molecular level information to uncover and comprehend metabolic changes relevant in various neurological applications.

13 June 2014
Verified
Conference Paper
Closed access
DBDavid Buchta
David Buchta
AAAaron Thomas Anderson
Aaron Thomas Anderson
JFJonathan B. Freund
Jonathan B. Freund

1 November 2024 in Neurosurgery
Verified
Journal Article
Closed access
ASAnnabelle Shaffer
Annabelle Shaffer
HKHelen Kemprecos
Helen Kemprecos
ZMZelda Moran
Zelda Moran
AAAaron Thomas Anderson
Aaron Thomas Anderson
ATAdam Tarr
Adam Tarr
PAPaul M Arnold
Paul M Arnold
BACKGROUND AND OBJECTIVES: Over a million sport-related concussions (SRC) affect children annually in the United States, posing a significant public health concern. Limited data exist on the premorbid risk factors and injury characteristics of SRCs in high school athletes. This study aims to understand acute SRC injury characteristics and describe premorbid risk factors in high school athletes. METHODS: Athletes (aged 14-19 years) from 19 central Illinois high schools participating in school-sponsored sports from 2009 to 2023 were included. Sports Concussion Assessment Tool evaluations were performed as part of preseason and postinjury evaluations. Injury characteristics, such as mechanism, setting, and symptoms, were described using all SRCs in the study period. Odds ratios (OR) were computed to determine risk factors using athletes with a baseline Sports Concussion Assessment Tool before SRC and nonconcussed athletes. RESULTS: In total, 4360 athletes were included (3953 without SRC; 407 with ≥1 SRC of whom 168 had a previous baseline). Overall, 24.2% of SRCs occurred in female athletes, and most SRCs occurred in competitions while playing American football (52.3%), soccer (20.4%), and basketball (7.6%). Blow/hit to the head was the most common mechanism. Headache was the most severe symptom (2.55 ± 1.51 [SD]), and symptoms of emotionality and nervousness/anxiety were significantly more severe in female athletes (P < .05). Students with previous concussions (OR 2.64 95% CI [1.81, 3.78]), previous hospitalization for head injury (OR 3.19 95% CI [1.9, 5.14]), headache/migraine disorders (OR 2.23 95% CI [1.29, 3.66]), and learning disabilities (OR 2.69 95% CI [1.47, 4.61]) had greater odds of SRC (P < .05). Lower odds of SRC were seen in athletes identifying as Black or African American (vs White) (OR 0.54 95% CI [0.32, 0.86]) and those attending larger (vs smaller) schools (OR 0.64 95% CI [0.46, 0.88]). CONCLUSION: Understanding SRC risk factors and characteristics in high school athletes is critical for developing prevention and management programs, guiding neurosurgeons in mitigating SRC risk, and informing return-to-play decisions.